Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcella Pesce

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Therapeutic Advances in Chronic Disease|March 31, 2021
Advances and caveats in modern achalasia managementMarcella Pesce, Rami Sweis
Current Opinion in Pharmacology|September 16, 2018
Endocannabinoids in the treatment of gasytrointestinal inflammation and symptomsMarcella Pesce, Giuseppe Esposito, Giovanni Sarnelli
United European Gastroenterology Journal|February 14, 2018
Complementary and alternative treatment in functional dyspepsiaGiuseppe Chiarioni, Marcella Pesce, Alberto Fantin, et al.
International Journal of Molecular Sciences|August 2, 2017
Gastro-Esophageal Reflux in ChildrenAnna Rybak, Marcella Pesce, Nikhil Thapar, et al.
Gastroenterology Clinics of North America|October 20, 2018
Gastrointestinal Neuropathies: New Insights and Emerging TherapiesMarcella Pesce, Osvaldo Borrelli, Efstratios Saliakellis, et al.
Journal of Neurogastroenterology and Motility|October 10, 2023
Modern Achalasia: Diagnosis, Classification, and TreatmentMarcella Pesce, Marta Pagliaro, Giovanni Sarnelli, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 14, 2018
Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndromeEugenia Bruzzese, Marcella Pesce, Giovanni Sarnelli, et al.
World Journal of Gastrointestinal Pathophysiology|November 19, 2013
Genetic contribution to motility disorders of the upper gastrointestinal tractGiovanni Sarnelli, Alessandra D'Alessandro, Marcella Pesce, et al.
Rambam Maimonides Medical Journal|February 6, 2019
Achalasia: Insights into Diagnostic and Therapeutic Advances for an Ancient DiseaseAmir Mari, Kalp Patel, Mahmud Mahamid, et al.
Pharmacological Reports : PR|February 23, 2026
Rifaximin's therapeutic spectrum: approved indications and experimental insights into emerging usesIrene Palenca, Silvia Basili Franzin, Marcella Pesce, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Therapeutic Advances in Chronic Disease|March 31, 2021
Advances and caveats in modern achalasia managementMarcella Pesce, Rami Sweis
Current Opinion in Pharmacology|September 16, 2018
Endocannabinoids in the treatment of gasytrointestinal inflammation and symptomsMarcella Pesce, Giuseppe Esposito, Giovanni Sarnelli
United European Gastroenterology Journal|February 14, 2018
Complementary and alternative treatment in functional dyspepsiaGiuseppe Chiarioni, Marcella Pesce, Alberto Fantin, et al.
International Journal of Molecular Sciences|August 2, 2017
Gastro-Esophageal Reflux in ChildrenAnna Rybak, Marcella Pesce, Nikhil Thapar, et al.
Gastroenterology Clinics of North America|October 20, 2018
Gastrointestinal Neuropathies: New Insights and Emerging TherapiesMarcella Pesce, Osvaldo Borrelli, Efstratios Saliakellis, et al.
Journal of Neurogastroenterology and Motility|October 10, 2023
Modern Achalasia: Diagnosis, Classification, and TreatmentMarcella Pesce, Marta Pagliaro, Giovanni Sarnelli, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 14, 2018
Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndromeEugenia Bruzzese, Marcella Pesce, Giovanni Sarnelli, et al.
World Journal of Gastrointestinal Pathophysiology|November 19, 2013
Genetic contribution to motility disorders of the upper gastrointestinal tractGiovanni Sarnelli, Alessandra D'Alessandro, Marcella Pesce, et al.
Rambam Maimonides Medical Journal|February 6, 2019
Achalasia: Insights into Diagnostic and Therapeutic Advances for an Ancient DiseaseAmir Mari, Kalp Patel, Mahmud Mahamid, et al.
Pharmacological Reports : PR|February 23, 2026
Rifaximin's therapeutic spectrum: approved indications and experimental insights into emerging usesIrene Palenca, Silvia Basili Franzin, Marcella Pesce, et al.
Pageof 8